Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLOW: Transitioning to BIIB017 in Relapsing MS
NCT01939002Phase 3Completed
- Sponsor
- Biogen
- Start
- Nov 2013
- Primary completion
- Oct 2015
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon beta-1a in multiple sclerosis (MS), sponsored by Biogen. Started Nov 2013; status: completed.
02
Drugs
peginterferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01939002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01939002.